Filters
Other countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NR5A1 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
NR5A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Disorders of Sex Development Panel Invitae United States | 88 | 53 |
|
PreventionGenetics United States | 156 | 73 |
|
PreventionGenetics United States | 128 | 85 |
|
46,XX Disorders of Sex Development/Complete Gonadal Dysgenesis Panel Genetic Services Laboratory University of Chicago United States | 9 | 11 |
|
Genologica Medica Spain | 25 | 11 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
46,XY sex reversal: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 11 | 10 |
|
Gonadal Dysgenesis/ Agenesis , Panel Massive Sequencing (NGS) SRY, NR5A1, DHH, AK2 Reference Laboratory Genetics Spain | 7 | 4 |
|
46 XX Sex Reversal Type 4 , Sequencing NR5A1 Reference Laboratory Genetics Spain | 1 | 1 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.